WHO Warns Dementia Population to Triple by 2050

As the global population ages, the number of people living with dementia is expected to triple in the next 30 years.

Dementia / Image: Daily Caring
Dementia / Image: Daily Caring

A December 7th Alzheimer’s Society article discussed a statement released by the World Health Organization saying the number of people living with dementia will rise from 50 million to 152 million by 2050. Dementia isn’t a specific disease, but rather a group of conditions with characterized by the impairment of at least two functions of the brain, like memory loss and judgment.

According to the WHO, the global cost of dementia is estimated to be $818 billion, which is more than 1% of the global GDP. This includes direct medical costs, social care, and informal care, and that cost is expected to more than double by 2030. Dominic Carter, Senior Policy Officer at Alzheimer’s Society, says that with an ageing population and no way to cure, prevent or slow the condition, dementia will likely be the biggest killer of the 21st century.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report